Turk Ilac ve Serum Sanayi AS Cash Flow Quality Index
Turk Ilac ve Serum Sanayi AS cash flow quality index. Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow Quality Index of 0.37x as of September 2025. Operating cash flow of TL44.50 Million is below net income of TL119.01 Million, suggesting accrual-heavy earnings not yet converted to cash. See Turk Ilac ve Serum Sanayi AS (TRILC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Turk Ilac ve Serum Sanayi AS (2018–2024)
Cash flow quality index of Turk Ilac ve Serum Sanayi AS from 2018 to 2024. Historical Cash Flow Quality Index for Turk Ilac ve Serum Sanayi AS across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Turk Ilac ve Serum Sanayi AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Turk Ilac ve Serum Sanayi AS Cash Flow Quality Index by Year (2018–2024)
Turk Ilac ve Serum Sanayi AS cash flow quality index by year from 2018 to 2024. Year-by-year earnings quality comparison for Turk Ilac ve Serum Sanayi AS. For the full cash flow conversion analysis, see TRILC operating cash flow.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -5.23x | TL-378.48 Million | TL72.36 Million | ▼ -295.6% |
| 2023 | 2.67x | TL408.19 Million | TL152.63 Million | ▲ +1594.2% |
| 2022 | -0.18x | TL-11.88 Million | TL66.38 Million | ▲ +90.7% |
| 2021 | -1.93x | TL-71.67 Million | TL37.14 Million | ▼ -293.7% |
| 2020 | 1.00x | TL33.20 Million | TL33.33 Million | ▲ +0.8% |
| 2019 | 0.99x | TL13.32 Million | TL13.48 Million | ▼ -62.7% |
| 2018 | 2.65x | TL38.13 Million | TL14.39 Million | — |